Sexual dimorphism: Is it relevant to steroid resistance or asthma control? - 15/08/11
Doi : 10.1016/j.jaci.2009.08.029
Gary M. Hunninghake, MD, MPH, Diane R. Gold, MD, MPH ⁎ 
Division of Pulmonary, Critical Care and Sleep Medicine, and Channing Laboratory, Department of Medicine, Brigham and Women’s Hospital; and Harvard Medical School, Boston, Mass
Reprint requests: Diane R. Gold, MD, MPH, Channing Laboratory, 181 Longwood Ave, Boston, MA 02115-5804.Key words : Sex, gender, asthma, allergy, chronic obstructive pulmonary disease, steroid, inhaled steroid, corticosteroid, glucocorticoid, steroid resistance
Le texte complet de cet article est disponible en PDF.
| Disclosure of potential conflict of interest: D. R. Gold has received research support from the National Institutes of Health; G. M. Hunninghake has declared he has no conflicts of interest. |
© 2009
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 124 - N° 4
P. 688-690 - octobre 2009 Retour au numéro
Article précédent
- Phenotypic determinants of uncontrolled asthma
- Valérie Siroux, Anne Boudier, Jean Bousquet, Jean-Louis Bresson, Jean-Luc Cracowski, Joane Ferran, Frédéric Gormand, Jocelyne Just, Nicole Le Moual, Sophie Morange, Rachel Nadif, Marie-Pierre Oryszczyn, Christophe Pison, Pierre Scheinmann, Raphaëlle Varraso, Daniel Vervloet, Isabelle Pin, Francine Kauffmann, Epidemiological Study on the Genetics and Environment of Asthma
- Reports of suicidality in clinical trials of montelukast
- George Philip, Carolyn Hustad, Gertrude Noonan, Marie-Pierre Malice, Alan Ezekowitz, Theodore F. Reiss, Barbara Knorr
Déjà abonné à cette revue ?